Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Also known as: Advanced Diffuse Large B-Cell Lymphoma (DLBCL)

DrugDrug NameDrug Description
DB00073RituximabA monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis.
DrugDrug NameTargetType
DB00073RituximabB-lymphocyte antigen CD20target
DrugDrug NamePhaseStatusCount
DB00316Acetaminophen2Active Not Recruiting1
DB00958Carboplatin2Active Not Recruiting1
DB09110Coenzyme M2Active Not Recruiting1
DB00531Cyclophosphamide2Active Not Recruiting1
DB01234Dexamethasone2Active Not Recruiting1
DB01075Diphenhydramine2Active Not Recruiting1
DB00997Doxorubicin2Active Not Recruiting1
DB00773Etoposide2Active Not Recruiting1
DB01181Ifosfamide2Active Not Recruiting1
DB00904Ondansetron2Active Not Recruiting1
DB00635Prednisone2Active Not Recruiting1
DB00073Rituximab2Active Not Recruiting1
DB00541Vincristine2Active Not Recruiting1